Evidence map›Paper›PMID 28500463›Full record

Trial reportEuropean journal of pediatrics2017

Comparison of four different intraosseous access devices during simulated pediatric resuscitation. A randomized crossover manikin trial.

Karol Bielski, Lukasz Szarpak, Jacek Smereka, Jerzy R Ladny, Steve Leung, Kurt Ruetzler

Open access · hybridAbstract readComparative StudyRandomized Controlled Trial
In one paragraph

Trial report in European journal of pediatrics, 2017. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 7 papers.

0numbers the graph read from it
0cells of the map it votes in
7citing papers in PubMed
1.9field-weighted citation impact, top 14% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

7 citing papers in PubMed, 26 citations in OpenAlex.

  1. Trial
  2. [Intraosseous access in infants-development of an anatomical training model].Medizinische Klinik, Intensivmedizin und Notfallmedizin · 2026
    Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. [Paediatric Life Support].Notfall & rettungsmedizin · 2021
    Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors at 4 institutions in 2 countries.

Karol BielskiMEDITRANS The Voivodship Emergency Medical Service and Sanitary Transport, Warsaw, Poland.
Lukasz SzarpakDepartment of Emergency Medicine, Medical University of Warsaw, Lindleya 4 Street, 02-005, Warsaw, Poland. Lukasz.szarpak@gmail.com.ORCID http://orcid.org/0000-0002-0973-5455
Jacek SmerekaDepartment of Emergency Medical Service, Wroclaw Medical University, Wroclaw, Poland.
Jerzy R LadnyDepartment of Emergency Medicine and Disaster, Medical University Bialystok, Bialystok, Poland.
Steve LeungDepartment of Outcomes Research, Cleveland Clinic, Cleveland, OH, USA.
Kurt RuetzlerDepartment of Outcomes Research, Cleveland Clinic, Cleveland, OH, USA.
Cleveland Clinic · USMedical University of Białystok · PLMedical University of Warsaw · PLWroclaw Medical University · PL

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

The aim of the study was to compare the success rate, procedure time, and user satisfaction of pediatric NIO™ compared to Pediatric BIG®, EZ-IO®, and Jamshidi intraosseous access devices. This was a randomized, crossover manikin trial with 87 paramedics. The correct location of intraosseous access when using NIO, BIG, EZ-IO, and Jamshidi was varied and was respectively 100, 90, 90, and 90%. The time required to obtain intravascular access (time T1) in the case of NIO, BIG, EZ-IO, and Jamshidi was varied and amounted to 9 s [IQR, 8-12] for NIO, 12 s [IQR, 9-16] for BIG, 13.5 s [IQR, 11-17] for the EZ-IO, and 15 s [IQR, 13-19] for Jamshidi. The paramedics evaluated each device on the subjective ease with which they performed the procedures. The intraosseous device, which proved the easiest to use was NIO, which in the case of CPR received a median rating of 1.5 (IQR, 0.5-1.5) points.

conclusionOur study found that NIO® is superior to BIG®, EZ-IO®, and Jamshidi. NIO® achieved the highest first attempt success rate. NIO® also required the least time to insert and easiest to operate even by novice users. Further study is needed to test our findings in cadavers or human subjects. Based on our findings, NIO® is a promising intraosseous device for use in pediatric resuscitation. What is Known: • Venous access in acutely ill pediatric patients, such as those undergoing cardiopulmonary resuscitation, is needed for prompt administration of drugs and fluids. • Intraosseous access is recommended by American Heart Association and European Resuscitation council if vascular access is not readily obtainable to prevent delay in treatment. What is New: • This simulated pediatric resuscitation compared performance of four commercially available pediatric intraosseous devices in a manikin model. • NIO® outperformed BIG®, EZ-IO®, and Jamshidi in first attempt success rates and time of procedure among novice users.

Indexed as

AdultAllied Health PersonnelChildCross-Over StudiesFemaleHumansInfusions, IntraosseousMaleManikinsPediatricsResuscitationCardiopulmonary resuscitationIntraosseous accessParamedicPediatricSimulation

Identifiers

PMID28500463
PMCPMC5486567
OpenAlexW2612448097

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.